Stock listing

TPEx:4192 SynCore Biotechnology Co., Ltd. (杏國) 股價

Follow SynCore Biotechnology Co., Ltd. into a list and get an email when it puts out news.

Share price · TPEX:4192

$15.75 TWD -0.45 (-2.8%)

Close on Nov 20, 2026

Past year -36.9% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$15.05 – $15.75 TWDNov 20, 2026
Volume
9,010 sharesNov 20, 2026
Market cap
$553.8M TWDAt the close on Nov 20, 2026 · price × 35.16M shares outstanding
52-week range
$15.05 – $26.50 TWDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$217,909 TWDMedian day 7,000 shares · 8 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026
SynCore Biotechnology Co., Ltd. logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · TPEX:4192 · TWD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$15.75-0.45-2.8%$15.10$15.75$15.059,010
$16.20+0.45+2.9%$16.45$16.45$16.204,871
$15.75+0.55+3.6%$15.20$15.75$15.203,271
$15.20-0.40-2.6%$15.20$15.20$15.108,001
$15.60-0.15-1.0%$15.60$15.70$15.6013,269
$15.75-0.20-1.3%$15.75$15.75$15.754,920
$15.95-0.50-3.0%$15.70$15.95$15.5512,219
$16.45-0.10-0.6%$15.60$16.45$15.6021,008
$16.55+0.75+4.7%$16.20$16.55$16.203,001
$15.80-0.80-4.8%$15.30$16.15$15.3012,001
$16.60+0.05+0.3%$16.70$16.70$16.105,001
$16.55-0.20-1.2%$16.75$16.75$16.057,000
$16.75-0.10-0.6%$16.45$16.75$16.0515,000
$16.85-0.05-0.3%$16.50$16.85$16.508,432
$16.90+0.40+2.4%$16.50$16.90$16.3019,611
$16.50-0.30-1.8%$16.75$16.75$16.5021,145
$16.80-0.40-2.3%$17.00$17.00$16.804,535
$17.20+0.20+1.2%$17.00$17.20$17.008,001
$17.000.000.0%$17.00$17.00$17.000
$17.00-0.45-2.6%$17.10$17.10$17.003,001
$17.45+0.30+1.7%$17.35$17.45$17.352,001
$17.15-1.20-6.5%$17.25$17.65$17.1533,673
$18.35+0.15+0.8%$18.00$18.35$18.006,001
$18.20-0.50-2.7%$17.60$18.20$17.605,651
$18.700.000.0%$18.70$18.70$18.700
$18.70+0.80+4.5%$17.85$18.70$17.606,500
$17.90-0.10-0.6%$18.00$18.00$17.9017,000
$18.00+0.20+1.1%$17.80$18.10$17.7533,002
$17.80+0.30+1.7%$17.55$17.80$17.5042,000
$17.50-0.30-1.7%$17.80$17.80$17.5052,018
$17.80-0.85-4.6%$18.10$18.25$17.7555,000
$18.650.000.0%$18.65$18.65$18.650
$18.650.000.0%$18.65$18.65$18.650
$18.65+0.20+1.1%$18.45$18.65$18.454,500
$18.45+0.30+1.7%$18.45$18.45$17.655,122
$18.150.000.0%$18.15$18.15$18.150
$18.15+0.05+0.3%$18.15$18.15$18.151,000
$18.10-0.50-2.7%$18.00$18.10$17.9011,801
$18.60+0.30+1.6%$18.50$18.60$18.506,000
$18.30+0.15+0.8%$17.95$18.30$17.957,000
$18.15-1.30-6.7%$18.80$18.80$17.7528,373
$19.45+0.60+3.2%$18.20$19.45$18.205,534
$18.850.000.0%$18.85$18.85$18.850
$18.85+0.60+3.3%$18.20$18.85$18.2011,000
$18.25-0.65-3.4%$18.25$18.25$18.255,000
$18.90+0.35+1.9%$18.55$18.90$18.4027,172
$18.55-0.30-1.6%$18.40$18.70$18.405,000
$18.850.000.0%$18.85$18.85$18.850
$18.85-0.05-0.3%$18.65$18.85$18.4012,205
$18.90+0.40+2.2%$18.30$18.90$18.307,000
$18.50-0.75-3.9%$18.65$18.80$18.5048,000
$19.25+0.25+1.3%$19.25$19.25$19.251,801
$19.00-0.05-0.3%$18.55$19.00$18.554,000
$19.050.000.0%$19.05$19.05$19.053,000
$19.05-0.90-4.5%$19.15$19.15$19.0016,000
$19.950.000.0%$19.95$19.95$19.950
$19.95-0.05-0.3%$19.30$19.95$19.3029,064
$20.000.000.0%$19.50$20.00$19.0030,576
$20.000.000.0%$20.00$20.00$19.5012,006
$20.00+0.55+2.8%$19.10$20.00$19.0013,329
$19.45-0.05-0.3%$19.00$20.00$19.0011,122

Splits

1 split · TPEX:4192 · every price before a split is adjusted for it

DayRatioWhat
1-for-3.743Consolidation
Ticker
TPEx:4192
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
TPEx
Currency
TWD

SynCore Biotechnology Co., Ltd. on 6ix

Sector
Health care
Industry
Biotechnology

Valuation

EV/sales 15.6× against a median of 1.7×: the highest of 3 Biotechnology companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026

Enterprise value
$408.0M TWD
P/E
Loss
EV/sales
15.6×
EV/EBITDA
Negative EBITDA
Price/book
2.5×
Gross margin
81.4%
Operating margin
−185.8%
Net margin
−178.5%
Debt to equity
0.0×
Beta
No index for this market yet

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
SynCore Biotechnology Co., Ltd. · TPEX:4192US$16.80MUS$12.38Mn/a15.6×n/a2.5×−178.5%0.0×n/a
Resverlogix Corp. · TSX:RVXUS$18.01MUS$95.55Mn/an/an/an/an/an/a0.26
Initiator Pharma A/S · OMXSTO:INITUS$16.74MUS$15.65Mn/an/an/a13.4×n/a1.1×n/a
Neurotech International Ltd. · ASX:NTIUS$16.63MUS$15.06Mn/an/an/a41.1×n/a0.0×n/a
Akari Therapeutics PLC · NASDAQ:AKTXUS$16.41MUS$10.66Mn/an/an/a0.9×n/a0.0×1.49
Lipocine Inc. · NASDAQ:LPCNUS$16.39M−US$5.07Mn/a−1.4×n/a0.8×−249.2%0.0×1.18
MaaT Pharma · EURONEXT:MAATUS$16.11MUS$23.36Mn/a4.7×n/an/a−686.6%n/an/a
Elicera Therapeutics AB · OMXSTO:ELICUS$16.09MUS$10.40Mn/an/an/a2.9×n/a0.0×n/a
Pasithea Therapeutics Corp. · NASDAQ:KTTAUS$16.00M−US$25.22Mn/an/a−0.1×0.4×n/a0.0×0.97
Atossa Therapeutics, Inc. · NASDAQ:ATOSUS$15.92M−US$4.66Mn/an/an/a0.7×n/a0.0×0.87
Quoin Pharmaceuticals. Ltd · NASDAQ:QNRXUS$15.76M−US$17.43Mn/an/an/a0.6×n/a0.0×0.68
Median of the othersUS$16.25MUS$10.53M1.7×−0.1×0.9×−467.9%0.0×0.92

Team and board

Officers

OfficerRole
Chih Wen LeeFounder, Chairman / CEO
Hui-Hung WangDirector of Oncology
Muh-Hwan SuGeneral Manager

Board

DirectorRole
Chih Wen LeeFounder, Chairman / CEO
Yita LeeDeputy Chairman

Financials

Annual, in TWD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue27.0M23.3M20.2M15.9M6.94M13.3M13.0M7.71M8.14M6.90M
Cost of revenue5.96M10.4M19.7M6.77M3.97M7.15M4.70M3.64M4.07M3.65M
Gross profit21.1M12.9M521.0K9.09M2.97M6.19M8.27M4.07M4.07M3.25M
Research and development24.5M28.3M3.94M157.2M423.0M363.2M380.1M257.6M224.3M208.5M
Selling, general and administrative43.8M42.3M33.3M36.2M34.9M35.1M44.8M47.5M39.7M38.4M
Operating income-47.2M-57.8M-37.4M-186.4M-456.6M-395.5M-416.6M-301.0M-260.0M-243.7M
Depreciation and amortization17.6M18.2M19.7M40.1M52.4M56.5M16.7M8.25M46.6M46.4M
EBITDA-29.6M-39.6M-17.7M-146.3M-404.1M-339.1M-399.9M-292.8M-213.4M-197.3M
Interest expense173.0K302.0K784.0K2.27M2.04M3.39M2.04M982.0K00
Income before tax-45.8M-54.3M-38.2M-188.7M-458.6M-398.9M-408.6M-294.1M-258.0M-162.2M
Net income-45.8M-54.3M-38.2M-188.7M-458.6M-398.9M-408.6M-294.1M-258.0M-162.2M
Earnings per share, basic-1.30-1.54-1.19-6.14-14.87-14.12-4.20-3.53-3.69

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents157.3M205.5M264.7M269.1M553.0M539.2M386.4M472.6M462.7M712.0M
Short-term investments7.07M6.96M6.66M6.66M6.66M6.66M6.66M6.66M6.66M6.66M
Receivables5.59M2.27M35.9M54.4M131.2M170.9M24.7M22.5M20.3M15.3M
Inventory9.68M10.1M3.12M17.5M17.2M17.9M107.7M37.4M11.5M5.99M
Current assets215.3M260.5M310.5M348.2M710.7M742.0M538.9M545.2M502.0M747.9M
Property, plant and equipment14.8M11.1M27.8M43.2M12.6M17.8M13.6M
Total assets255.7M317.8M378.4M436.6M824.4M914.0M763.9M804.8M845.9M1.11B
Accounts payable1.06M9.32M0315.0K655.0K11.4M732.0K367.0K751.0K4.66M
Current liabilities10.1M22.1M21.2M186.6M381.5M348.1M133.4M63.3M55.4M49.2M
Total debt2.11M71.8M125.5M228.8M
Total liabilities10.1M23.1M21.2M187.6M381.5M353.4M151.8M98.1M125.3M148.5M
Shareholders' equity245.6M294.7M357.1M249.0M442.9M560.6M612.0M706.7M720.6M966.4M
Shares outstanding35.2M35.2M32.1M30.7M30.8M28.3M97.4M83.4M69.9M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-38.3M-49.2M-82.4M-209.6M-229.9M-316.6M-418.6M-272.3M-202.0M-195.1M
Capital spending-406.0K-457.0K-761.0K-1.04M-1.64M-6.02M-3.55M-2.99M-12.2M-6.69M
Free cash flow-38.7M-49.7M-83.1M-210.6M-231.5M-322.7M-423.5M-277.4M-215.9M-201.8M
Cash from investing-1.03M-1.64M-5.64M-3.43M-6.65M-13.9M158.5M
Cash from financing78.7M-73.2M245.3M475.1M335.8M288.9M-33.5M310.7M
Share buybacks324.0M
Change in cash-48.2M-59.2M-4.45M-283.8M13.7M152.9M-86.3M9.96M-249.3M274.1M

Open Financials

Cap table

Built by 6ix from SynCore Biotechnology Co., Ltd.’s releases

Common shares
35,165,000
Fully diluted
35,165,000

Fully diluted

LineShares
Common shares35,165,000

Share count over time

CountShares
Nov 22, 202635,165,000

Open Cap table

Shareholders

HolderSharesOf the companyAs of
杏輝藥品工業股份有限公司22.6M64.3%Oct 31, 2026
楊蕙華145K0.41%Oct 31, 2026
李易達15,4630.04%Oct 31, 2026
陳至孝5,2670.01%Oct 31, 2026
許競爵1,000<0.01%Oct 31, 2026
陳佩姍00.00%Oct 31, 2026
陳蒨慧00.00%Oct 31, 2026
張福星00.00%Oct 31, 2026
張金堅00.00%Oct 31, 2026
陳章龍00.00%Oct 31, 2026
All 16 holders
HolderSharesOf the companyAs of
吳燕秋00.00%Oct 31, 2026
呂慧青00.00%Oct 31, 2026
陳明珠00.00%Oct 31, 2026
郭漢鵬00.00%Oct 31, 2026
王惠弘00.00%Oct 31, 2026
杏輝藥品工業股份有限公司Nov 22, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Chih Wen LeeFounder, Chairman / CEO · Since at least Nov 5, 2026
Hui-Hung WangDirector of Oncology · Since at least Nov 5, 2026
Muh-Hwan SuGeneral Manager · Since at least Nov 5, 2026
Yita LeeDeputy Chairman · Since at least Nov 5, 2026

Open People

Log in to ask 6ix AI your own questions about SynCore Biotechnology Co., Ltd.